Bacterial species are able to colonize and establish communities in biotic and abiotic surfaces. Moreover, within the past five decades, incidence of bacterial strains resistant to currently used antibiotics has increased dramatically. This has led to diverse health issues and economical losses for different industries. Therefore, there is a latent need to develop new and more efficient antimicrobials. This work reports an increased production of an exopolysaccharide in a native yeast strain isolated from the Mexican Northeast, Rhodotorula mucilaginosa UANL-001L, when co-cultured with E. coli. The exopolysaccharide produced is chemically and physically characterized and its applications as an antimicrobial and antibiofilm are explored. The exopolysaccharide is capable of inhibiting planktonic growth and biofilm formation in Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Additionally, the exopolysaccharide studied here does not exhibit cytotoxic effects when assessed both, in vitro against an H9c2 mammalian cell line, and in vivo in a murine toxicity model. Taken together, the properties of this exopolysaccharide indicate that it has potential applications to inhibit bacterial colonization in medical and industrial settlings.Within the last five decades there has been an increased frequency in the emergence of bacterial strains resistant to commercially available antibiotics [1][2][3][4] . Therefore, there is an urgent need to seek, develop and design new antimicrobials to treat infections and to combat bacterial strains in industrial settings 5 . Bacteria have the ability to colonize biotic and abiotic environments through the formation of biofilms 6 . It has been estimated that 80% of bacterial infections in humans are caused by bacterial biofilms, and 50% of the nosocomial infections are